Market evolution: Medical furniture and chairs (CN 9402) — 2015–2025

Introduction

This report examines the evolution of EU trade in Medical, surgical, dental or veterinary furniture (CN 9402) over the period 2015–2025. The product category covers operating tables, examination tables, hospital beds with mechanical fittings, dentists' and barbers' chairs, and parts thereof. The EU has maintained a structural trade surplus throughout the decade, yet the period was marked by diverging trajectories: strong and steady export growth, a dramatic acceleration of imports (especially from China and Türkiye), and a pandemic-driven spike in both volumes and prices. The analysis is organised around three main themes—aggregate market dynamics, geographic and internal EU structure, and the EU's strategic positioning in terms of vulnerability and resilience.

1. A Decade of Diverging Import and Export Trajectories

1.1 Exports grew in value while volumes stagnated

Between 2015 and 2025, EU exports of CN 9402 rose from €687 million to €929 million (+35.3%). However, the quantity exported barely changed, moving from 36,748 tonnes to 36,459 tonnes (−0.8%). This means that the value increase was almost entirely driven by a surge in unit export prices, which climbed from €18,690/t to €25,484/t (+36.4%).

The 2020 pandemic year stands out: export volumes surged to 50,225 tonnes (the decade's peak), while prices dipped to their lowest point (€17,165/t). This likely reflects a combination of emergency procurement demand from third countries and possible discounting. From 2021 onward, volumes reverted to pre-pandemic levels, but prices climbed sharply, reaching a peak of €26,507/t in 2024 before a slight correction in 2025.

1.2 Import growth was far more dramatic, doubling in value

EU imports grew from €265 million to €534 million (+101.9%)—roughly triple the pace of exports. Crucially, unlike exports, imports grew substantially in both volume and price: quantities rose from 29,048 tonnes to 53,705 tonnes (+84.9%), while prices edged up from €9,113/t to €9,949/t (+9.2%).

A striking feature is the persistent and widening price gap: EU exports command roughly 2.5 times the unit price of imports (€25,484/t vs. €9,949/t in 2025). This suggests that the EU specialises in higher-value, technology-intensive medical furniture (premium operating tables, advanced hospital beds), while imports are concentrated in lower-cost, higher-volume products (basic examination tables, standard chairs, parts).

1.3 The trade surplus narrowed despite export value growth

The EU's trade surplus in CN 9402 fell from €422 million to €395 million (−6.5%). While this remains a comfortable margin, the trajectory is noteworthy: import growth is systematically outpacing export growth. The net import reliance indicator (negative values indicate net exports) moved from −17.8% to −20.1%, confirming that the EU remains a net exporter, but that its relative position is eroding slightly.

2. Shifting Geographic Patterns and Internal EU Specialisation

2.1 China and Türkiye emerged as the fastest-growing import sources

Among the EU's top import partners, China dominates and grew the most in absolute terms: imports from China rose from €87 million to €223 million (+156.1%), making it by far the largest single supplier. Türkiye displayed the fastest relative growth (+379.8%), rising from €6 million to €29 million—a sign of the country's emerging role as a medical furniture manufacturing hub.

The US remains the second-largest import source (€152 million), reflecting transatlantic supply chains in medical equipment. The UK's position (€48 million) is notable in the post-Brexit context, with moderate growth (+37.7%) suggesting continuity but perhaps some friction effects.

Import concentration (HHI) by value rose from 2,285 to 2,696 (+18.0%), indicating that import sourcing became more concentrated over the decade—largely driven by China's growing share. In volume terms, the increase was even steeper (from 3,893 to 5,481, +40.8%).

2.2 Export destinations remained diversified, led by the US and UK

The EU's export geography is notably more diversified than its import base. The US was the largest destination (€186 million, +52.0%), followed by the UK (€106 million, +31.5%), Switzerland (€74 million, +42.0%), and Norway (€53 million, +68.3%). Saudi Arabia (+25.8%) and Norway (+68.3%) stood out as fast-growing non-EU destinations, likely linked to hospital infrastructure investments in the Gulf region and Nordic countries' healthcare modernisation.

Export concentration remained relatively low (HHI rising modestly from 656 to 715, +9.0%), confirming that the EU sells to a broad range of markets.

2.3 Germany anchors the EU's export base; the Netherlands and Czechia showed the strongest growth

Among EU Member States, Germany was by far the largest exporter of CN 9402 (€320 million in 2025), accounting for roughly one-third of total EU exports. Czechia (+77.2%) and the Netherlands (+170.2%) showed the strongest growth among major exporters, with the Netherlands rising from €37 million to €100 million. This likely reflects both genuine manufacturing expansion and the Netherlands' role as a logistics hub.

On the import side, the Netherlands (+239.6%) and Ireland (+230.1%) experienced the most dramatic import surges, while Germany (+70.5%) and Spain (+155.5%) also posted strong increases. The Netherlands' import growth to €151 million further underlines its role as a distribution gateway.

Specialisation analysis for 2025 reveals that Poland (RSCA: 0.35), Finland (0.29), and Czechia (0.28) are the most specialised EU exporters of medical furniture relative to their overall trade profiles. Conversely, Luxembourg, Ireland, Belgium, and Hungary are the least specialised, with negative RSCA values indicating net import dependence in this product category.

3. Resilience, Price Dynamics, and Structural Shifts

3.1 The pandemic triggered a temporary volume shock followed by sustained price inflation

The 2020 pandemic year created a clear discontinuity in the data. Export volumes spiked to 50,225 tonnes (+28% above 2019), reflecting emergency demand for hospital beds, examination tables, and related equipment. Import volumes also rose, reaching 40,515 tonnes. From 2021, volumes normalised on the export side but continued climbing on the import side.

The more lasting effect was on prices. Price shock detection identified several significant events: a sharp export price increase to the UK in 2021 (+47.5%, abnormality 27.5), and a notable price shock to South Africa in 2022 (+26.2%). These likely reflect post-pandemic cost pressures (raw materials, energy, labour) and supply chain disruptions that raised the price floor for EU-manufactured medical furniture.

3.2 The EU's production base expanded substantially

EU production of CN 9402 grew from €1.10 billion to €2.50 billion in value (+128.0%), and from 5.56 million to 8.16 million units in quantity (+46.7%). The faster growth in value than in quantity points to a structural shift toward higher-value products—possibly linked to increasing digitisation, integration of electronics, and premium features in medical furniture.

This production expansion is consistent with the EU's growing trade intensity (from 31.4% to 47.6%) and export propensity (from 24.8% to 37.0%). The EU's medical furniture sector has become more internationally oriented, exporting a larger share of its output while also importing more to meet domestic demand.

3.3 Import volatility is rising, signalling potential supply-chain risks

Volatility analysis reveals that import flows are considerably more volatile than export flows. Among key import partners, Tunisia (CV: 0.84), India (0.62), Türkiye (0.51), and Hong Kong (0.42) display the highest coefficients of variation, indicating unpredictable year-to-year fluctuations. By contrast, EU export flows to major destinations are more stable, with Switzerland (CV: 0.06), the US (0.12), and Norway (0.12) showing low volatility.

The combination of rising import concentration (HHI up 18%), growing dependence on China (now 42% of imports by value), and elevated volatility from secondary suppliers suggests that while the EU's trade surplus remains healthy, its import supply chain is becoming more exposed to geopolitical and logistical risks. The growing reliance on a small number of Asian suppliers for basic medical furniture and parts could become a vulnerability if trade tensions or supply disruptions intensify.

Conclusion

The EU's medical furniture trade (CN 9402) over 2015–2025 tells a story of a robust, high-value export sector facing an increasingly competitive and concentrated import landscape. EU exports grew steadily in value—driven almost entirely by price increases rather than volume gains—while imports more than doubled, powered by surging volumes from China and a rising Türkiye. The EU maintains a significant trade surplus and a strong production base that has more than doubled in value, but the narrowing surplus and rising import concentration point to shifting competitive dynamics. The pandemic acted as a short-term volume shock and a lasting price catalyst, accelerating pre-existing trends toward higher unit values. Going forward, the key challenge for the EU medical furniture sector will be to sustain its premium positioning while managing growing import dependence and the supply-chain risks that accompany it.